Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
A business making money today isn’t necessarily a winner, which is why we analyze companies across multiple dimensions at StockStory. That said, here is one profitable company that generates reliable profits without sacrificing growth and two that may face some trouble.
Two Stocks to Sell:
IQVIA (IQV)
Trailing 12-Month GAAP Operating Margin: 13%
Created from the 2016 merger of Quintiles (a clinical research organization) and IMS Health (a healthcare data specialist), IQVIA (NYSE: IQV) provides clinical research services, data analytics, and technology solutions to help pharmaceutical companies develop and market medications more effectively.
Why Does IQV Give Us Pause?
- The company has faced growth challenges as its 5.6% annual revenue increases over the last five years fell short of other healthcare companies
- Adjusted operating margin was unchanged over the last two years, suggesting it failed to gain leverage on its fixed costs
- Free cash flow margin didn’t grow over the last five years
IQVIA’s stock price of $271.65 implies a valuation ratio of 19.3x forward P/E. Dive into our free research report to see why there are better opportunities than IQV.
SLB (SLB)
Trailing 12-Month GAAP Operating Margin: 14.6%
What began in 1926 with two brothers logging the first electrical measurements in a well, SLB (NYSE: SLB) provides technology and services to help oil and gas companies locate reservoirs, drill wells, and produce hydrocarbons.
Why Does SLB Fall Short?
- Gross margin of 21.4% is below its competitors, leaving less money to invest in exploration and production
At $57.68 per share, SLB trades at 20.5x forward P/E. Check out our free in-depth research report to learn more about why SLB doesn’t pass our bar.
One Stock to Watch:
Flex (FLEX)
Trailing 12-Month GAAP Operating Margin: 5%
Originally known as Flextronics until its 2016 rebranding, Flex (NASDAQ: FLEX) is a global manufacturing partner that designs, engineers, and builds products for companies across industries from medical devices to solar trackers.
Why Do We Like FLEX?
- Massive revenue base of $29.27 billion makes it a well-known name that influences purchasing decisions
- Exciting sales outlook for the upcoming 12 months calls for 26.2% growth, an acceleration from its two-year trend
- Performance over the past two years was turbocharged by share buybacks, which enabled its earnings per share to grow faster than its revenue
Flex is trading at $107 per share, or 20.2x forward P/E. Is now the time to initiate a position? See for yourself in our comprehensive research report, it’s free.
Stocks We Like Even More
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.
